Home
About
Technology
Pipeline
Investors
News
Contact

Bioshares | July 2020

July 20, 2020

Patrys was featured in the latest issue of BioShares in an article titled, “Patrys – Synthetic Lethality to Kill Cancer Cells”.

Patrys Limited

Patrys is a publicly-listed company company focused on developing novel antibody technologies for cancer and NETosis-driven inflammatory diseases

Newsletter

Get news and updates from Patrys delivered to your inbox.

Stay Connected

Keep up to date with the latest news from Patrys by following us on social media.

© 2021 Patrys Limited. All rights reserved.

ASX
Privacy Policy

Menu